Tower Research Capital »

Aerovate Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $61k 2.1k 29.57
2023-09-30 $20k 1.4k 13.57
2023-06-30 $16k 908 17.15
2023-03-31 $55k 2.7k 20.45
2022-12-31 $34k 1.1k 29.72
2022-09-30 $57k 3.4k 16.53
2022-06-30 $8.0k 515 15.53
2022-03-31 $26k 1.4k 18.34
2021-12-31 $37k 3.1k 11.84
2021-09-30 $9.0k 414 21.74
2021-06-30 $5.0k 235 21.28